Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation

Toxicology and Applied Pharmacology
M E AndersenC R Eklund

Abstract

A physiologically based pharmacokinetic (PBPK) model for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was combined with a five-compartment geometric model of hepatic zonation to predict both total and regional induction of CYP450 proteins within the liver. Three literature studies on TCDD pharmacokinetics and protein induction in female rats were analyzed. In simulating low-dose behavior for mRNA in whole liver and, particularly, in representing immunohistochemical observations, the five-compartment model was more successful than conventional homogeneous one-compartment liver models. The five-compartment liver model was used with the affinity of TCDD for the Ah receptor (AhR) held constant across all the liver (Kb = 0.2 nM). The presumed affinities of the AhR-TCDD complex for TCDD responsive elements in the CYP1A1 (Kd1) and CYP1A2 (Kd2) genes varied between adjacent compartments by a factor of 3. This parameterization leads to predicted 81-fold differences in affinities between the centrilobular and the periportal regions. The affinities used for AhR-TCDD complex binding to TCDD response elements for CYP1A2 in compartment 3 (the midzonal area) ranged from 0.08 to 1.0 nM in the three studies modeled. For CYP1A1 the corresponding d...Continue Reading

References

May 1, 1976·Toxicology and Applied Pharmacology·J Q RoseP J Gehring
Jul 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·W H LamersA F Moorman
May 1, 1987·Toxicology and Applied Pharmacology·T C Sloop, G W Lucier
Sep 15, 1987·Toxicology and Applied Pharmacology·D W Brewster, L S Birnbaum
Mar 15, 1983·Toxicology and Applied Pharmacology·F G KingL S Birnbaum
Feb 1, 1993·Risk Analysis : an Official Publication of the Society for Risk Analysis·M E AndersenW F Greenlee

❮ Previous
Next ❯

Citations

Jul 27, 2000·Food Additives and Contaminants·L Poellinger
Jul 27, 2000·Food Additives and Contaminants·C Portier
Feb 18, 2003·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Rakesh DixitMelvin E Andersen
Nov 16, 2007·Toxicological Sciences : an Official Journal of the Society of Toxicology·Melvin E AndersenKendall B Wallace
Feb 4, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Sudin BhattacharyaQiang Zhang
Mar 14, 2003·Environmental Health Perspectives·Melvin E AndersenJames E Dennison
Aug 13, 2011·Environmental Health Perspectives·Shu Cheng, Frederic Y Bois
Jul 28, 1999·Environmental Health Perspectives·M E AndersenL Ziese
Jan 22, 2005·Risk Analysis : an Official Publication of the Society for Risk Analysis·Leona H ClarkHugh A Barton
Oct 18, 2008·Chemico-biological Interactions·K Sandy Pang
Mar 1, 2005·Trends in Biotechnology·Melvin E AndersenRory B Conolly
Jan 31, 2006·Toxicology and Applied Pharmacology·Wakae Maruyama, Yasunobu Aoki
Aug 2, 2005·Regulatory Toxicology and Pharmacology : RTP·Michael Schwarz, Klaus E Appel
Jul 7, 2015·Regulatory Toxicology and Pharmacology : RTP·Richard A BeckerRobert A Budinsky
Jul 24, 2008·Dose-response : a Publication of International Hormesis Society·Nigel J Walker, Jae-Ho Yang
Jul 24, 2008·Dose-response : a Publication of International Hormesis Society·John F ReichardAlvaro Puga
Jun 9, 2016·Toxicology·Frédéric Y BoisAndrew Worth
Sep 6, 2002·Chemico-biological Interactions·Timothy P DaltonHoward G Shertzer
Mar 1, 2004·Environmental Toxicology and Pharmacology·Melvin E Andersen, James E Dennison
Mar 12, 2004·Toxicological Sciences : an Official Journal of the Society of Toxicology·C Tenley FrenchMelvin E Andersen
Jul 19, 2008·Archives of Toxicology·Sabine PlöttnerWolfram Föllmann
Dec 15, 2010·Journal of Pharmacokinetics and Pharmacodynamics·K Sandy Pang, Matthew R Durk
Jul 15, 1998·Human & Experimental Toxicology·J G TeeguardenH C Pitot
Mar 15, 2000·Journal of Applied Toxicology : JAT·J G TeeguardenH C Pitot
Sep 24, 2005·Annals of the New York Academy of Sciences·William SlikkerDonald R Mattison
Feb 15, 2007·Journal of Applied Toxicology : JAT·Weihsueh A ChiuKannan Krishnan
May 31, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Y KapelyukhC R Wolf
Jun 1, 1997·Regulatory Toxicology and Pharmacology : RTP·H A Barton, M E Andersen
Feb 1, 2003·Toxicology Letters·Melvin E Andersen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.